Mount Sinai Researcher Identifies Best Practices for Hearing Preservation in Cochlear Implant Patients
Findings could transform treatment worldwide and enhance patient care
Cochlear implants that have electrodes designed without wire perform better than those with wires for long-term hearing preservation, a Mount Sinai researcher has reported in a first-of-its-kind study. The research also determined that the best surgical approach for cochlear implant procedures did not involve drilling into the bone around the ear. The results, published in the June 23, 2017, online edition of The Laryngoscope, may transform how doctors approach cochlear implant procedures to give patients the best possible outcomes.
Cochlear implants help preserve hearing in patients with nerve deafness who cannot benefit from hearing aids. They are surgically placed in the inner ear to convert sound waves into electrical signals that stimulate the auditory nerve to provide hearing.
“This is the largest clinical study done in the world on conventional electrodes and will have major implications for doctors and their patients who need their long-term hearing restored,” said the study’s lead investigator, George Wanna, MD, Site Chair, Department of Otolaryngology-Head and Neck Surgery at New York Eye and Ear Infirmary of Mount Sinai (NYEE) and Mount Sinai Beth Israel; Chief, Division of Otology-Neurotology and Director of the Center for Hearing and Balance and Ear Institute at Mount Sinai Health System. “This study is a breakthrough for patients with hearing loss, and improvements in practice and techniques will allow them to enjoy many hearing benefits such as music enjoyment, listening in complex environments, and sound localization.”
Dr. Wanna and a team of researchers from Vanderbilt University examined roughly 230 patients with every type of cochlear implant, including three FDA-approved implants that use different types of electrodes to stimulate the auditory nerve. They found that electrodes designed with no wire (called lateral wall electrodes) performed the best in maintaining residual hearing in the inner ear, compared to electrodes made with wire. More specifically, the non-wire electrodes were less traumatic, causing less injury and minimizing fractures inside the inner ear. The study found that the actual brand of the electrode did not make a difference; the presence or absence of wire was the only distinguishing factor.
Dr. Wanna and the researchers also looked at the impact of two major surgical approaches used to insert the electrodes in the inner ear: “round window” (where surgeons open the membrane without bone removal or drilling in the inner ear) and “cochleostomy” (which requires drilling into the bone to get inside the inner ear). They reported that patients who had the round window approach had a much better chance of keeping their residual hearing in the long term.
“The cochleostomy approach causes fibrosis and scarring, leading to hearing loss over time,” said Dr. Wanna. “Our results also revealed that using oral steroids also helped in the long term to preserve hearing by preventing inflammation.”
“We hope the findings will help surgeons choose the best implants and approaches for their patients,” said Dr. Wanna. “This is an exciting time in this field, and the advancement in hearing technology and continued improvements in techniques and outcomes will benefit patients and their families.”
This research was supported by the National Institute on Deafness and Other Communication Disorders the National Center for Advanced Translational Sciences.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Mount Sinai Returns as Official Health Care Partner of the US Open Tennis Championships
Aug 20, 2026 View All Press Releases
The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report®
Aug 04, 2026 View All Press Releases
Loss of Radiation Therapy Clinics Could Widen Cancer Care Gaps Across the United States
Jul 10, 2026 View All Press Releases
